BRIEF-EMA Says Recommended Authorising Use Of Nuvaxovid As Booster Dose

European Medicines Agency:

* EMA: EMA'S CHMP RECOMMENDED AUTHORISING THE USE OF NUVAXOVID AS A BOOSTER DOSE FOR ADULTS WHO HAVE RECEIVED THE SAME OR ANOTHER COVID-19 VACCINE FOR THEIR INITIAL VACCINATION: 01/09/2022

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)